This site is intended for US healthcare professionals

Hero Header

INFLAMMATION AND FIBROSIS ARE DAMAGING YOUR PATIENTS' KIDNEYS1,2

Luiza Caramori, MD, PhD, MSc, explains the role of MR overactivation in inflammation and fibrosis

Inflammation and fibrosis are a largely unaddressed driver of CKD progression in patients with T2D. MR overactivation can trigger the production of proinflammatory and profibrotic proteins, which may lead to irrevocable kidney damage.1-7

Inflammation and fibrosis in the kidneys can lead to albuminuria and a decline in kidney function8

Thank you for visiting our site. The questions you'll see throughout are completely voluntary. If you choose to answer the questions, you'll gain access to our video library and other resources.

Thank you for your response

CKD organ damage kidney icon

Learn more about the kidney damage that can occur when inflammation and fibrosis are left largely unaddressed1,2

Next page

CKD: chronic kidney disease; MR: mineralocorticoid receptor; T2D: type 2 diabetes.

References:

  • Tesch GH, et al. Front Pharmacol. 2017;8. doi:10.3389/fphar.2017.00313.
  • Alicic RZ, et al. Clin J Am Soc Nephrol. 2017;12(12):2032–2045.
  • Toth-Manikowski S, et al. J Diabetes Res. 2015;2015. doi:10.1155/2015/697010.
  • Black LM, et al. J Histochem Cytochem. 2019;67(9):663–681.
  • Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. Kidney Int Suppl. 2013;3(1):1–150.
  • Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. Kidney Int. 2020;98(4S):S1–S115.
  • American Diabetes Association. Diabetes Care. 2021;44(suppl 1):S1–S232.
  • Thomas MC, et al. Nat Rev Dis Primers. 2015;1. doi:10.1038/nrdp.2015.18.